Levels of anxiety and depression seen in people who have a common heart rhythm disorder called atrial fibrillation may be affected by how the heart condition is treated, a new study suggests.
Sep 18, 2018
0
5
(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.
Apr 12, 2017
0
0
Dear Mayo Clinic: My dad was diagnosed with hypertrophic cardiomyopathy at age 52. He has been on medication for a few months, but doctors said he likely will need surgery, even though his symptoms are very mild. Is surgery ...
May 6, 2016
0
21
Researchers have discovered how to predict some cardiac arrhythmias several steps before they even occur. It's a finding that could lead to an improved cardiac device, with equipment designed to detect when arrhythmias are ...
Sep 28, 2015
0
11
(HealthDay)—When used by patients with mechanical heart valves, the blood thinner Pradaxa raises the risk of both dangerous clots and bleeding around the heart, a new study says.
Sep 26, 2013
0
0
A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical ...
Oct 1, 2012
0
0
Sudden cardiac death is a risk for patients with heart failure because the calcium inside their heart cells is not properly controlled and this can lead to an irregular heartbeat. New findings published in PLoS ONE, which ...
Feb 22, 2012
0
0
New research from Western University, Canada, has demonstrated the benefits of performing Cardiovascular Magnetic Resonance (CMR) in cases where patients have been resuscitated after Sudden Cardiac Death or enter hospital ...
Feb 14, 2012
0
0
UC Davis researchers have developed an accurate computer model to test the effects of medications for arrhythmia, or abnormal heart rhythm, before they are used in patients.
Aug 31, 2011
0
0
